T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.15B |
| 2 |
Apple
AAPL
|
+$742M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$647M |
| 4 |
Flowserve
FLS
|
+$577M |
| 5 |
Visa
V
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWSA
NEWS CORPORATION CL-A
NWSA
|
+$909M |
| 2 |
Union Pacific
UNP
|
+$741M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$580M |
| 4 |
Edwards Lifesciences
EW
|
+$531M |
| 5 |
Accenture
ACN
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.66% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 11.61% |
| 5 | Technology | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARTC
1001
DELISTED
ARTHROCARE CORP
ARTC
| $26.6M | 0.01% |
746,987
+700
| +0.1% | +$24.4K |
|
|
WY.PRA
1002
DELISTED
WEYERHAEUSER COMP PREF CONV SER A (WA)
WY.PRA
| $26.4M | 0.01% |
+504,000
| New | +$26.5M |
|
1003
T. Rowe Price
TROW
$23.8B
| $26.4M | 0.01% |
367,194
-34,400
| -9% | -$2.55M |
|
|
HTS
1004
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $26.2M | 0.01% |
1,399,970
-213,000
| -13% | -$4.28M |
|
|
FRED
1005
DELISTED
Fred's Inc
FRED
| $26.1M | 0.01% |
1,665,014
-25,421
| -2% | -$420K |
|
|
COL
1006
DELISTED
Rockwell Collins
COL
| $26M | 0.01% |
383,593
| – | – |
|
|
WIRE
1007
DELISTED
Encore Wire Corp
WIRE
| $25.8M | 0.01% |
655,145
+71,090
| +12% | +$2.77M |
|
1008
Coca-Cola Consolidated
COKE
$12.6B
| $25.6M | 0.01% |
4,086,100
+7,000
| +0.2% | +$44.5K |
|
|
BCR
1009
DELISTED
CR Bard Inc.
BCR
| $25.5M | 0.01% |
221,494
-580,037
| -72% | -$66.5M |
|
1010
Gen Digital
GEN
$17.7B
| $25.5M | 0.01% |
1,028,648
-4,190
| -0.4% | -$105K |
|
|
ULTI
1011
DELISTED
Ultimate Software Group Inc
ULTI
| $25.2M | 0.01% |
171,000
-8,200
| -5% | -$1.14M |
|
|
XNPT
1012
DELISTED
XENOPORT, INC.
XNPT
| $25.2M | 0.01% |
4,434,612
-1,578,899
| -26% | -$8.24M |
|
1013
Public Service Enterprise Group
PEG
$37.8B
| $25.2M | 0.01% |
764,636
-1,990
| -0.3% | -$65.9K |
|
1014
Tapestry
TPR
$25.9B
| $25.1M | 0.01% |
459,425
-1,990
| -0.4% | -$110K |
|
|
AMRN
1015
Amarin Corp
AMRN
$297M
| $25M | 0.01% |
198,010
-4,575
| -2% | -$548K |
|
1016
Oceaneering
OII
$5.08B
| $25M | 0.01% |
308,000
-3,400
| -1% | -$273K |
|
1017
Eagle Materials
EXP
$6.47B
| $25M | 0.01% |
344,508
-160
| -0% | -$10.9K |
|
|
RSTI
1018
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $24.9M | 0.01% |
1,027,950
+1,420
| +0.1% | +$33.7K |
|
|
CGI
1019
DELISTED
Celadon Group Inc
CGI
| $24.9M | 0.01% |
1,331,200
-200
| -0% | -$3.78K |
|
|
CBK
1020
DELISTED
Christopher & Banks Corporation
CBK
| $24.8M | 0.01% |
3,440,927
-5,375
| -0.2% | -$35.6K |
|
|
VPHM
1021
DELISTED
VIROPHARMA INC
VPHM
| $24.8M | 0.01% |
630,200
-1,018,000
| -62% | -$33.3M |
|
|
DATA
1022
DELISTED
Tableau Software, Inc.
DATA
| $24.6M | 0.01% |
346,016
-444,330
| -56% | -$28.6M |
|
|
ALEX
1023
DELISTED
Alexander & Baldwin
ALEX
| $24.6M | 0.01% |
683,430
+97,580
| +17% | +$3.9M |
|
1024
Globus Medical
GMED
$11.5B
| $24.4M | 0.01% |
+1,398,685
| New | +$24.2M |
|
1025
United Therapeutics
UTHR
$21.9B
| $24.4M | 0.01% |
308,920
+4,300
| +1% | +$314K |
|
Similar funds
T. Rowe Price Associates's Q3 2013 Portfolio in Review
As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
- T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
- T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
- T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
- T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
- T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.
Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.